These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 8240725

  • 41. Drug-induced corneal epithelial changes.
    Raizman MB, Hamrah P, Holland EJ, Kim T, Mah FS, Rapuano CJ, Ulrich RG.
    Surv Ophthalmol; 2017; 62(3):286-301. PubMed ID: 27890620
    [Abstract] [Full Text] [Related]

  • 42. Ocular changes induced by drugs commonly used in dermatology.
    Turno-Kręcicka A, Grzybowski A, Misiuk-Hojło M, Patryn E, Czajor K, Nita M.
    Clin Dermatol; 2016; 34(2):129-37. PubMed ID: 26903180
    [Abstract] [Full Text] [Related]

  • 43. Ocular effects of topical and systemic steroids.
    Renfro L, Snow JS.
    Dermatol Clin; 1992 Jul; 10(3):505-12. PubMed ID: 1617809
    [Abstract] [Full Text] [Related]

  • 44. [Visual impairment due to optic neuropathy in 2 patients on amiodarone therapy, i.e. ethambutol and isoniazide].
    Polak BC, Tutein Nolthenius PA, Rietveld E.
    Ned Tijdschr Geneeskd; 2001 May 12; 145(19):922-6. PubMed ID: 11387869
    [Abstract] [Full Text] [Related]

  • 45. Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey.
    Ramakrishnan R, Nirmalan PK, Krishnadas R, Thulasiraj RD, Tielsch JM, Katz J, Friedman DS, Robin AL.
    Ophthalmology; 2003 Aug 12; 110(8):1484-90. PubMed ID: 12917161
    [Abstract] [Full Text] [Related]

  • 46. Hemorrhagic ocular complications associated with the use of systemic thrombolytic agents.
    Chorich LJ, Derick RJ, Chambers RB, Cahill KV, Quartetti EJ, Fry JA, Bush CA.
    Ophthalmology; 1998 Mar 12; 105(3):428-31. PubMed ID: 9499772
    [Abstract] [Full Text] [Related]

  • 47. Ocular diseases and 10-year mortality: the Beijing Eye Study 2001/2011.
    Wang YX, Zhang JS, You QS, Xu L, Jonas JB.
    Acta Ophthalmol; 2014 Sep 12; 92(6):e424-8. PubMed ID: 24612916
    [Abstract] [Full Text] [Related]

  • 48. Ophthalmic Complications Related to Chemotherapy in Medically Complex Patients.
    Harman LE.
    Cancer Control; 2016 Apr 12; 23(2):150-6. PubMed ID: 27218792
    [Abstract] [Full Text] [Related]

  • 49. Screening for tamoxifen ocular toxicity: a prospective study.
    Therssen R, Jansen E, Leys A, Rutten J, Meyskens J.
    Eur J Ophthalmol; 1995 Apr 12; 5(4):230-4. PubMed ID: 8963159
    [Abstract] [Full Text] [Related]

  • 50. Adverse ocular reactions to drugs.
    Spiteri MA, James DG.
    Postgrad Med J; 1983 Jun 12; 59(692):343-9. PubMed ID: 6356101
    [Abstract] [Full Text] [Related]

  • 51. Miotic drugs: a review of ocular, visual, and systemic complications.
    Rengstorff R, Royston M.
    Am J Optom Physiol Opt; 1976 Feb 12; 53(2):70-80. PubMed ID: 1084694
    [Abstract] [Full Text] [Related]

  • 52. Statin-associated ocular disorders: the FDA and ADRAC data.
    Mizranita V, Pratisto EH.
    Int J Clin Pharm; 2015 Oct 12; 37(5):844-50. PubMed ID: 25939673
    [Abstract] [Full Text] [Related]

  • 53. Bilateral ocular hypertension with rapidly progressive optic neuropathy in a teen.
    Hua LV, Byrne E, Yudcovitch L.
    Optom Vis Sci; 2009 Sep 12; 86(9):E1117-26. PubMed ID: 19661835
    [Abstract] [Full Text] [Related]

  • 54. Ocular side-effects of tolterodine and oxybutynin, a single-blind prospective randomized trial.
    Altan-Yaycioglu R, Yaycioglu O, Aydin Akova Y, Guvel S, Ozkardes H.
    Br J Clin Pharmacol; 2005 May 12; 59(5):588-92. PubMed ID: 15842558
    [Abstract] [Full Text] [Related]

  • 55. Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing.
    Newnham DM.
    Drug Saf; 2001 May 12; 24(14):1065-80. PubMed ID: 11735662
    [Abstract] [Full Text] [Related]

  • 56. Systemic and local tolerability of ophthalmic drug formulations. An update.
    Hugues FC, Le Jeunne C.
    Drug Saf; 1993 May 12; 8(5):365-80. PubMed ID: 8099291
    [Abstract] [Full Text] [Related]

  • 57. [Computerized perimetry in infants treated with ethambutol (author's transl)].
    Gramer E, Jeschke R, Krieglstein GK.
    Klin Padiatr; 1982 Jan 12; 194(1):52-5. PubMed ID: 6977676
    [Abstract] [Full Text] [Related]

  • 58. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF, Wattiaux MJ, Van Amerongen AP.
    Encephale; 2001 Jan 12; 27(6):588-99. PubMed ID: 11865567
    [Abstract] [Full Text] [Related]

  • 59. Optometric implications of systemic drug therapy.
    Canon SH.
    J Am Optom Assoc; 1985 Nov 12; 56(11):843-4. PubMed ID: 4078206
    [Abstract] [Full Text] [Related]

  • 60. [Ocular side effects of drugs].
    Müller-Breitenkamp U, Hockwin O.
    Laryngorhinootologie; 1992 Apr 12; 71(4):226-8. PubMed ID: 1575856
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.